clinicaltrialsarena2h
Vaxcyte doses first subject in pneumococcal conjugate vaccine trial in infants
Vaxcyte has commenced the Phase II trial of its 31-valent pneumococcal conjugate vaccine (PCV) candidate, VAX-31, in healthy infants.
clinicaltrialsarena4h
Patient data understanding must be a priority in trials, say expert panel
Clinical Trials in Oncology conference a panel urged trial designers to be considerate of what they are asking from patients.
clinicaltrialsarena4h
VivaVision to advance non-steroidal therapy in Phase III following Phase II win
Vivavision’s non-steroidal immunomodulator met the primary endpoint in a Phase II trial as a post-op inflammation treatment after cataract surgery.
clinicaltrialsarena4h
Arrowhead seeks approval to begin RNAi therapy trial for obesity treatment
Arrowhead Pharmaceuticals has sent an application to the New Zealand regulator seeking clearance to commence a Phase I/IIa trial of ARO-ALK7.
clinicaltrialsarena6h
Medical firms urged not to let assumptions put patients at risk
Clinical Trials in Oncology conference, healthcare companies were urged to keep rigorous records during clinical trials.